Drs. Benjamin Adegbite and Evren Azeloglu discuss the results of their study, "Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity," on behalf of their colleagues.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
